103 related articles for article (PubMed ID: 6186879)
1. Pharmacological actions of levallorphan allyl bromide (CM 32191), a new peripheral narcotic antagonist.
Bianchetti A; Giudice A; Picerno N; Carminati P
Life Sci; 1982 Nov 15-22; 31(20-21):2261-4. PubMed ID: 6186879
[TBL] [Abstract][Full Text] [Related]
2. Levallorphan methyl iodide (SR 58002), a potent narcotic antagonist with peripheral selectivity superior to that of other quaternary compounds.
Dragonetti M; Bianchetti A; Sacilotto R; Giudice A; Ferrarese N; Cattaneo C; Manara L
Life Sci; 1983; 33 Suppl 1():477-80. PubMed ID: 6664228
[TBL] [Abstract][Full Text] [Related]
3. The peripheral narcotic antagonist N-allyl levallorphan-bromide (CM 32191) selectively prevents morphine antipropulsive action and buprenorphine in-vivo binding in the rat intestine.
Bianchi G; Fiocchi R; Peracchia F; Petrillo P; Tavani A; Manara L
J Pharm Pharmacol; 1984 May; 36(5):326-30. PubMed ID: 6145770
[TBL] [Abstract][Full Text] [Related]
4. Relative ability of N-methyl nalorphine and N-methyl levallorphan to prevent antinociception and intestinal transit inhibition in morphine treated rats.
Notarnicola A; Landi M; Bianchi G; Tavani A
Life Sci; 1983; 33 Suppl 1():481-4. PubMed ID: 6664229
[TBL] [Abstract][Full Text] [Related]
5. Effect of morphine on adrenergic transmission in the mouse vas deferens. Assessment of agonist and antogonist potencies of narcotic analgesics.
Hughes J; Kosterlitz HW; Leslie FM
Br J Pharmacol; 1975 Mar; 53(3):371-81. PubMed ID: 236796
[TBL] [Abstract][Full Text] [Related]
6. Identification of opioid ligands possessing mixed micro agonist/delta antagonist activity among pyridomorphinans derived from naloxone, oxymorphone, and hydromorphone [correction of hydropmorphone].
Ananthan S; Khare NK; Saini SK; Seitz LE; Bartlett JL; Davis P; Dersch CM; Porreca F; Rothman RB; Bilsky EJ
J Med Chem; 2004 Mar; 47(6):1400-12. PubMed ID: 14998329
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of gastrointestinal transit by morphine and FK 33-824 in the rat and comparative narcotic antagonist properties of naloxone and its N-methyl quaternary analog.
Manara L; Bianchi G; Fiocchi R; Notarnicola A; Peracchia F; Tavani A
Life Sci; 1982 Sep 20-27; 31(12-13):1271-4. PubMed ID: 6183550
[TBL] [Abstract][Full Text] [Related]
8. Effects of methylnaltrexone on morphine-induced inhibition of contraction in isolated guinea-pig ileum and human intestine.
Yuan CS; Foss JF; Moss J
Eur J Pharmacol; 1995 Mar; 276(1-2):107-11. PubMed ID: 7781680
[TBL] [Abstract][Full Text] [Related]
9. Agonist and antagonist actions of morphine-like drugs on the guinea-pig isolated ileum.
Gyand EA; Kosterlitz HW
Br J Pharmacol Chemother; 1966 Sep; 27(3):514-27. PubMed ID: 5970903
[No Abstract] [Full Text] [Related]
10. Kinetic parameters of narcotic agonists and antagonists, with particular reference to N-allylnoroxymorphone (naloxone).
Kosterlitz HW; Watt AJ
Br J Pharmacol Chemother; 1968 Jun; 33(2):266-76. PubMed ID: 5664147
[No Abstract] [Full Text] [Related]
11. Antagonism by N-methyl levallorphan-methane sulphonate (SR 58002 C) of morphine-elicited acute and chronic central and peripheral effects.
Sbacchi M; Colombo M; La Regina A; Petrillo P; Tavani A
Life Sci; 1988; 42(21):2079-89. PubMed ID: 3386393
[TBL] [Abstract][Full Text] [Related]
12. Chloroxymorphamine, and opioid receptor site-directed alkylating agent having narcotic agonist activity.
Caruso TP; Takemori AE; Larson DL; Portoghese PS
Science; 1979 Apr; 204(4390):316-8. PubMed ID: 86208
[TBL] [Abstract][Full Text] [Related]
13. The effect of quaternary naloxone on the increased naloxone potency induced by morphine.
Wong CL; Wai MK
Clin Exp Pharmacol Physiol; 1984; 11(5):467-71. PubMed ID: 6084569
[TBL] [Abstract][Full Text] [Related]
14. Analgesic activity and pharmacological characterization of N-[1-phenylpyrazol-3-yl]-N-[1-(2-phenethyl)-4-piperidyl] propenamide, a new opioid agonist acting peripherally.
Goicoechea C; Sánchez E; Cano C; Jagerovic N; Martín MI
Eur J Pharmacol; 2008 Oct; 595(1-3):22-9. PubMed ID: 18706410
[TBL] [Abstract][Full Text] [Related]
15. Increased biological activity of dimers of oxymorphone and enkephalin: possible role of receptor crosslinking.
Hazum E; Chang KJ; Leighton HJ; Lever OW; Cuatrecasas P
Biochem Biophys Res Commun; 1982 Jan; 104(1):347-53. PubMed ID: 6176227
[No Abstract] [Full Text] [Related]
16. Quaternary derivatives of narcotic antagonists: stereochemical requirements at the chiral nitrogen for in vitro and in vivo activity.
Bianchetti A; Nisato D; Sacilotto R; Dragonetti M; Picerno N; Tarantino A; Manara L; Angel LM; Simon EJ
Life Sci; 1983; 33 Suppl 1():415-8. PubMed ID: 6319895
[TBL] [Abstract][Full Text] [Related]
17. Diastereoisomeric N-tetrahydrofurfurylnoroxymorphones with opioid agonist--antagonist properties.
Merz H; Stockhaus K; Wick H
J Med Chem; 1977 Jun; 20(6):844-6. PubMed ID: 69027
[TBL] [Abstract][Full Text] [Related]
18. Comparison of effect of [D-Arg2,Sar4]-dermorphin (1-4) and morphine on mouse small intestinal transit and electrically evoked contraction of guinea pig ileum.
Nakata N; Sakurada S; Sakurada T; Tan-No K; Kisara K
Methods Find Exp Clin Pharmacol; 1998 Apr; 20(3):193-8. PubMed ID: 9646281
[TBL] [Abstract][Full Text] [Related]
19. Opiate agonists and antagonists discriminated by receptor binding in brain.
Pert CB; Pasternak G; Snyder SH
Science; 1973 Dec; 182(4119):1359-61. PubMed ID: 4128222
[TBL] [Abstract][Full Text] [Related]
20. Social conflict analgesia: studies on naloxone antagonism and morphine cross-tolerance in male DBA/2 mice.
Rodgers RJ; Randall JI
Pharmacol Biochem Behav; 1985 Nov; 23(5):883-7. PubMed ID: 2417263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
